Anthony Atala

Dr. Anthony Atala


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MRMostafa Rezapour
Mostafa Rezapour
TSThomas D. Shupe
Thomas D. Shupe
DODavid A. Ornelles
David A. Ornelles
Sean MurphySean Murphy
Sean Murphy
AAAnthony Atala
Anthony Atala
Dengue virus (DENV) and chikungunya virus (CHIKV) co-circulate in many regions and present with overlapping clinical features, which complicate accurate diagnosis and disease management. This study develops an integrative transcriptomic framework to identify robust host gene signatures that distinguish between dengue, chikungunya, and healthy states. Publicly available RNA sequencing (RNA-seq) datasets derived from human blood samples were analyzed using a cross-validation design to ensure robustness and prevent information leakage. Differential expression analysis was performed independently within each dataset using the Generalized Linear Models with Quasi-Likelihood F-tests and Magnitude–Altitude Scoring (GLMQL-MAS) framework, followed by Cross-Magnitude–Altitude Scoring (Cross-MAS) integration to identify shared and virus-specific gene signatures. A strict consensus approach across folds was applied to derive reproducible gene sets. These signatures were used for dimensionality reduction and multinomial logistic regression to evaluate classification performance. A small subset of selected genes showed strong discriminative performance within the cross-validation framework, with test balanced accuracy reaching 0.97, which improved upon models using all genes. Biologically, both infections exhibited a shared antiviral response characterized by interferon signaling and innate immune activation. However, distinct virus-specific patterns were identified. Dengue infection was associated with cell-cycle and DNA replication pathways, while chikungunya infection showed stronger enrichment of inflammatory and immune signaling pathways, including NF-kappaB and Toll-like receptor signaling. Overall, this study provides a cross-validation-based framework for integrative transcriptomic analysis and identifies compact, reproducible host-response signatures with strong discriminative signals in the analyzed cohorts. These signatures require validation in larger independent cohorts before any clinical or diagnostic application.

27 June 2026 in Cells
Verified
Journal Article
Open access
PDF file
AEAya Abdel Raouf Eltaibany
Aya Abdel Raouf Eltaibany
Kathleen McGovernKathleen McGovern
Kathleen McGovern
GNGoodwell Nzou
Goodwell Nzou
DPDaniel Almeida Porada
Daniel Almeida Porada
MSMichael C. Seeds
Michael C. Seeds
AAAnthony Atala
Anthony Atala
Numerous central nervous system pathological conditions involve blood–brain barrier (BBB) disruption and the egress of immune cells in the brain. Controlling immune cell transmigration into the brain represents a potential therapeutic target. This study describes the application of a 3D human BBB spheroidal model that consists of six major brain cell types to test the transmigration of immune cells under normal and pathological conditions of inflammation and ischemia–reperfusion injury (IRI). The cell types in the BBB organoid include brain microvascular endothelial cells (HBMVECs) and pericytes at the spheroids’ surface, surrounding a core of astrocytes, microglia, oligodendrocytes, and neural progenitor cells. The model recapitulates the interaction of CD4+ T-cells and immunomodulators with HBMVECs at the BBB including changes in cell adhesion molecules expressed on their surface. This study demonstrated that the human 3D BBB model recapitulates many features of the barrier under normal and pathological conditions of inflammation and hypoxia-reperfusion injury. Proinflammatory cytokines and hypoxia disrupt the barrier and increase its permeability, decreasing the expression of tight junctions. Proinflammatory cytokines and reperfusion increase the expression of cell adhesion molecules and increase immune cell transmigration. Immune cell transmigration could be reduced with anti-cell adhesion molecule antibodies, further validating the model for studying neuroimmune interactions and for conducting high-throughput screening of therapeutic targets that modulate immune cell transmigration into the brain.

12 October 2026 in Antioxidants
Verified
Journal Article
Open access
PDF file
ACAdam Cohen
Adam Cohen
JHJanmejay Hingu
Janmejay Hingu
AUAbinav Udaiyar
Abinav Udaiyar
NZNima Pourhabibi Zarandi
Nima Pourhabibi Zarandi
BNBanafsheh Nikmehr
Banafsheh Nikmehr
HSHooman Sadriardekani
Hooman Sadriardekani
Oxidative stress driven by environmental and occupational exposure to heavy metals is increasingly recognized as a central, modifiable contributor to male infertility. Yet, the lack of physiologically relevant human models has limited mechanistic insight. We have previously described a three-dimensional Human Testis Tissue Equivalent (hTTE) that recapitulates the cellular composition and stem cell niche of the seminiferous tubule and is more resistant than two-dimensional (2D) culture to gonadotoxic chemotherapeutics. Here, we used the hTTE platform to compare heavy-metal cytotoxicity, cell-type–associated transcript responses, and exploratory microRNA (miRNA) profiles elicited by three prototypical pro-oxidant heavy metals: mercury (Hg2+), thallium (Tl+), and lead (Pb2+). Background and Aim: To determine whether the hTTE model exhibits greater resistance to heavy-metal cytotoxicity than matched 2D cultures and whether cell-type–associated responses differ following heavy-metal exposure within the established redox biology of these toxicants. Methods: Adult human testicular cells from three donors were expanded, characterized by RT-qPCR and flow cytometry, and assembled into hTTEs alongside matched 2D cultures. Cultures were exposed for 48 h to Hg2+, Tl+, or Pb2+ across graded concentrations; IC50 values were derived from ATP-based viability assays and used for selected downstream exposure concentrations. The relative abundances of cell-type–associated transcripts were profiled by digital PCR for ZBTB16 (spermatogonia), STAR (Leydig), SOX9 (Sertoli), and CD34 (peritubular cells), and global miRNA expression was quantified using the NanoString nCounter Human v3b miRNA panel (827 miRNAs). Exploratory Ingenuity Pathway Analysis of miRNA data was used to identify predicted mRNA associations with a testis/reproductive disease filter. Results: hTTEs exhibited significantly greater IC50 values than matched 2D cultures for all three metals (p < 0.05), demonstrating greater resistance to acute heavy-metal cytotoxicity in the hTTE culture system, consistent with enhanced antioxidant buffering in the 3D microenvironment. Metal-associated changes in cell-type marker transcripts were distinct: Hg2+ produced broad reductions in markers associated with all four populations; Pb2+ produced greater reductions in Sertoli and peritubular cell markers while relatively preserving spermatogonial and Leydig cell markers; and Tl+ reduced somatic support cell markers with relative enrichment of spermatogonial (~7-fold) and Leydig cell marker expression. Heavy-metal exposure was associated with exploratory miRNA changes previously linked to redox imbalance, BCL2-mediated apoptosis, MYC/CDKN1A-driven nucleolar stress, AHR/CYP1A1 activation, and EGFR/COX-2 signaling. Conclusions: These findings demonstrate greater resistance of the hTTE culture system to acute heavy-metal cytotoxicity and suggest metal-specific differences in testicular cell-type responses. Within the established redox biology of Hg2+, Tl+, and Pb2+, the observed patterns provide a framework for investigating oxidative stress mechanisms directly in a human-relevant testicular model. This system may provide a platform for future studies incorporating direct redox measurements and antioxidant rescue strategies.

Verified
Journal Article
Open access
PDF file
GNGemma Nomdedeu-Sancho
Gemma Nomdedeu-Sancho
NENicholas Edenhoffer
Nicholas Edenhoffer
AGAnastasiya Gorkun-Roeder
Anastasiya Gorkun-Roeder
OGOla A. Gaser
Ola A. Gaser
CKCarlos Kengla
Carlos Kengla
SSShay Soker
Shay Soker
Melanoma is the most aggressive type of skin cancer, driven by early invasion, phenotypic plasticity, and frequent resistance to targeted therapies. Although genomic profiling informs treatment selection, genotype alone often fails to predict therapeutic response, underscoring the need for rapid and physiologically relevant functional testing platforms. Here, we present a three-dimensional melanoma–skin organoid (mSO) model that integrates primary skin cells with melanoma cell lines in a self-assembling, high-throughput format. The spherical mSOs recapitulate native human skin architecture, including a stratified epidermis and a dermal–hypodermal core, while supporting melanoma growth within an appropriate tissue microenvironment. In this niche, melanoma cells display epidermal spreading in radial growth-like patterns, outward invasion, and transcriptional shifts toward a pro-invasive phenotype. Using live confocal imaging coupled with a custom automated image analysis pipeline, we quantitatively measured tumor growth, migration beyond the organoid boundary, and interactions between melanoma cells and normal melanocytes. The mSOs also captured genotype-specific drug responses: BRAF-mutant melanoma cells were sensitive to BRAF and MEK inhibition, whereas NRAS-mutant, BRAF–wild-type cells were resistant to BRAF inhibition but remained responsive to MEK inhibition. Altogether, our mSO platform combines architectural and functional complexity with experimental scalability, providing a robust framework for modeling melanoma progression and evaluating targeted therapeutic responses within a relevant skin microenvironment. In the future, adaptation of this system to include patient-derived tumor cells could support personalized therapeutic decision-making in melanoma.

Verified
Journal Article
Open access
PDF file
EPEMma Peveri
EMma Peveri
DBDaniella Beiner
Daniella Beiner
AHAndrew Huang
Andrew Huang
JMJian-Xing Ma
Jian-Xing Ma
AAAmish Asthana
Amish Asthana
Yuanyuan ZhangYuanyuan Zhang
Yuanyuan Zhang
Acute ocular injuries—such as chemical burns, ischemic insults, and mechanical trauma—frequently lead to irreversible vision loss by triggering rapid intracellular adenosine triphosphate (ATP) depletion, mitochondrial calcium overload, severe oxidative stress, and profound mitochondrial dysfunction. Current clinical management primarily focuses on suppressing inflammation and preventing secondary infection, but it fails to address the underlying bioenergetic collapse that drives cellular degeneration. While stem cell and extracellular vesicle therapies have been widely investigated, direct mitochondrial transplantation has recently emerged as a novel strategy for metabolic rescue. This review evaluates the therapeutic potential of exogenously administered mitochondria to mitigate mitochondrial dysfunction and acute trauma in the eye. Emerging preclinical studies demonstrate that transplanted mitochondria can be internalized by selected ocular cell types, conferring short-term cytoprotection, preserving retinal ganglion cell viability, and accelerating corneal epithelial repair. However, robust evidence regarding long-term mitochondrial integration, functional fusion, durable metabolic rescue, and clinical efficacy remains limited. Despite critical challenges in delivery, stability, and dosing, mitochondrial transplantation represents a promising frontier in regenerative ophthalmology that directly targets bioenergetic failure to preserve vision.

25 August 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
DBDaniella Beiner
Daniella Beiner
HZHainan Zhu
Hainan Zhu
CBCarol Christine Bosholm
Carol Christine Bosholm
TCTracy Criswell
Tracy Criswell
AAAnthony Atala
Anthony Atala
YZYuanyuan Zhang
Yuanyuan Zhang
Age-related macular degeneration (AMD), particularly its dry form, is a leading cause of irreversible vision loss due to retinal pigment epithelium (RPE) dysfunction and loss. Addressing this unmet therapeutic need requires non-invasive strategies for generating patient-specific RPE cells. This study reports the successful generation and initial characterization of RPE cells derived from urine-derived induced pluripotent stem cells (u-iPSC-RPE). Urine-derived stem cells (USCs) were isolated from healthy individuals and comprehensively characterized, confirming strong expression of renal progenitor makers and mesenchymal stem cell markers, while lacking standard hematopoietic markers. USCs were reprogrammed into iPSCs using the integration-free Sendai virus expressing the Yamanaka factors. The reprogrammed u-iPSC clones displayed characteristic pluripotency marker expression and demonstrated clearance of the Sendai virus by later passages. Subsequently, these u-iPSCs were efficiently differentiated into RPE cells, exhibiting characteristic hexagonal morphology and pigmentation which was confirmed by the expression of key RPE-specific proteins. Our findings demonstrated the feasibility of generating patient-specific RPE cells from readily accessible USCs. This reliable method for producing u-iPSC-RPE from urine-derived progenitor cells provides a promising foundation for future studies investigating their functional potential in vitro and their use in in vivo models for retinal disease modeling and therapeutic applications for AMD.